Journey Medical Corp Files 8-K on Director/Officer Changes

Ticker: DERM · Form: 8-K · Filed: Apr 3, 2025 · CIK: 1867066

Sentiment: neutral

Topics: corporate-governance, officer-changes, director-changes, financial-statements

TL;DR

Journey Medical Corp 8-K: Director/officer changes and financial updates filed April 3rd.

AI Summary

Journey Medical Corporation filed an 8-K on April 3, 2025, reporting events as of April 1, 2025. The filing pertains to the departure and election of directors, appointment of officers, and compensatory arrangements. It also includes financial statements and exhibits.

Why It Matters

This filing indicates potential shifts in the company's leadership and governance structure, which could impact strategic direction and operational oversight.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of corporate governance and financial information, not indicating immediate operational or financial distress.

Key Numbers

Key Players & Entities

FAQ

What specific changes occurred regarding directors or officers?

The filing indicates the departure of directors or certain officers and the election of directors and appointment of certain officers, though specific names are not detailed in this excerpt.

What is the effective date of the reported events?

The earliest event reported is dated April 1, 2025.

When was this 8-K filing submitted to the SEC?

The filing was submitted on April 3, 2025.

What are the main items covered in this 8-K filing?

The filing covers the departure/election of directors, appointment of officers, compensatory arrangements, and financial statements and exhibits.

Where is Journey Medical Corporation's principal executive office located?

The principal executive offices are located at 9237 E Via de Ventura Blvd., Suite 105, Scottsdale, AZ 85258.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 3, 2025 regarding Journey Medical Corp (DERM).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing